Biotech article - January 7, 2026
The European Commission has presented its proposed Biotech Act
The Biotech Act is an initiative to strengthen Europe's competitiveness in biotechnology and drug development.
Intellectual Property - January 7, 2026
Mucocort granted Swedish patent
The company has received a notice of approval for a Swedish patent covering the antimicrobial mechanism of action in its treatment patch, M045A, developed for the treatment of oral ulcers caused by aphthae (Recurrent Aphthous Stomatitis). The patent approval strengthens the company’s intellectual property portfolio and represents an important milestone ahead of the international PCT […]
In a new job - January 6, 2026
She is the new CEO of Alvotech
Alvotech has announced key senior leadership changes following a planned succession process.
In a new job - January 6, 2026
Nykode nominates new Chair of the Board
Nykode Therapeutics has announced the proposed election of Dr. Barbara Krebs-Pohl as the new Chair of the Board, succeeding Susanne Stuffers, who has served as interim Chair since April 2025.
Funding - January 6, 2026
Umeå Biotech Incubator awards grants for ‘Killer Experiments’
Three researchers at Umeå University and one at the Swedish University of Agricultural Sciences (SLU) have been granted funding through Umeå Biotech Incubator’s (UBI) call “Pre‑Incubator Funding for Critical Experiments in Life Science.”
In a new job - January 5, 2026
Gesynta Pharma forms Scientific Advisory Board
Gesynta Pharma has announced the formation of a Scientific Advisory Board (SAB) to provide strategic advice in the clinical development of vipoglanstat, a non-hormonal, non-opioid treatment for endometriosis that is currently in Phase 2 (the NOVA trial).
